Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
15000 participants
OBSERVATIONAL
2014-06-30
2027-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prognosis and Risk Factors of Gastric Cancer in Patients With Intestinal Metaplasia
NCT02325323
Clinic, Pathologic and Genetic Characterization of Patients With Familial Carcinoid Tumors (Study From the GTE, Groupe d'étude Des Tumeurs Endocrines)
NCT03622333
Prognostic Factors Affecting Survival of Gastric GIST
NCT04269941
G-POEM for Refractory Gastroparesis After Esophagectomy With Gastric Pull-through
NCT06068127
Study On Safety Of Endoscopic Resection For 2-5cm Gastric Gastrointestinal Stromal Tumor
NCT04751591
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Naive treatment for this cancer,
* Naive treatment for this cancer , failing that received neoadjuvant treatment ,
* Male or female ≥ 18 years.
* social protection scheme .
* sign a free and informed consent for blood sampling , the different questionnaires and the collection of patient information.
Exclusion Criteria
* Private person of liberty or under supervision (including guardianship ) .
* People who do not speak French.
* Major Nobody unable to consent .
* Patient FREGAT already included in the base.
* Patient Refusal .
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
French Eso-Gastric Tumors Working Group
OTHER
National Cancer Institute, France
OTHER_GOV
University Hospital, Lille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Guillaume Piessen, MD, PhD
Role: STUDY_DIRECTOR
University Hospital, Lille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chu Amiens Picardie
Amiens, , France
Chru Besancon
Besançon, , France
Hu Paris Site Avicenne Aphp
Bobigny, , France
Chu de Caen Normandie
Caen, , France
Crlcc Francois Baclesse
Caen, , France
Hopital Estaing - Chu63 - Clermont Ferrand
Clermont-Ferrand, , France
Hu Paris Nord Site Louis Mourier Aphp
Colombes, , France
Hopital Le Bocage Chru Dijon
Dijon, , France
Chu de Grenoble Alpes
Grenoble, , France
Hop Claude Huriez Chu Lille
Lille, , France
Clcc Oscar Lambret Lille
Lille, , France
C H U Dupuytren Limoges
Limoges, , France
Hospices Civils de Lyon (Pierre Bénite,Edouard Herriot, La Croix Rousse)
Lyon, , France
Aphm Hopital Nord
Marseille, , France
Hopital St Eloi Chu Montpellier
Montpellier, , France
Icm - Montpellier
Montpellier, , France
Chu de Nantes :Site Hôtel-Dieu- Hme
Nantes, , France
Chu Nimes
Nîmes, , France
Hu Est Parisien Site St Antoine Aphp
Paris, , France
Hu Paris Centre Site Cochin Aphp
Paris, , France
Hu Paris Sud Site Kremlin Bicetre Aphp
Paris, , France
Hu Saint Louis Site Saint Louis Aphp
Paris, , France
Hopital Haut-Leveque - Chu - Pessac
Pessac, , France
Hopital Robert Debre Chu Reims
Reims, , France
Chru Rennes Site Pontchaillou
Rennes, , France
Hopital Charles Nicolle Chu Rouen
Rouen, , France
Hus/Hop Hautepierre
Strasbourg, , France
Hopital Purpan Chu
Toulouse, , France
Chu de Tours
Tours, , France
Institut de Cancerologie de Lorraine
Vandœuvre-lès-Nancy, , France
Institut Gustave Roussy
Villejuif, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
guillaume Piessen, MD, PhD
Role: primary
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Mariette C, Renaud F, Piessen G, Gele P, Copin MC, Leteurtre E, Delaeter C, Dib M, Clisant S, Harter V, Bonnetain F, Duhamel A, Christophe V, Adenis A; Fregat Working Group. The FREGAT biobank: a clinico-biological database dedicated to esophageal and gastric cancers. BMC Cancer. 2018 Feb 6;18(1):139. doi: 10.1186/s12885-018-3991-8.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013-A01281-44
Identifier Type: OTHER
Identifier Source: secondary_id
2013_33
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.